MC1881A1 - Derives de l'acide phosphinique - Google Patents

Derives de l'acide phosphinique

Info

Publication number
MC1881A1
MC1881A1 MC871933A MC1933A MC1881A1 MC 1881 A1 MC1881 A1 MC 1881A1 MC 871933 A MC871933 A MC 871933A MC 1933 A MC1933 A MC 1933A MC 1881 A1 MC1881 A1 MC 1881A1
Authority
MC
Monaco
Prior art keywords
methyl
group
acid
carbamoyl
pentyl
Prior art date
Application number
MC871933A
Other languages
English (en)
French (fr)
Inventor
John Broadhurst Michael
Krishan Handa Balraj
Henry Johnson William
Lawton Geoffrey
James Machin Peter
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868629876A external-priority patent/GB8629876D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1881A1 publication Critical patent/MC1881A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MC871933A 1986-12-15 1987-12-10 Derives de l'acide phosphinique MC1881A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629876A GB8629876D0 (en) 1986-12-15 1986-12-15 Phosphinic acid derivatives
GB878722245A GB8722245D0 (en) 1986-12-15 1987-09-22 Phosphinic acid derivatives

Publications (1)

Publication Number Publication Date
MC1881A1 true MC1881A1 (fr) 1989-01-24

Family

ID=26291694

Family Applications (1)

Application Number Title Priority Date Filing Date
MC871933A MC1881A1 (fr) 1986-12-15 1987-12-10 Derives de l'acide phosphinique

Country Status (19)

Country Link
US (2) US4885283A (cs)
EP (1) EP0276436B1 (cs)
CN (1) CN1017337B (cs)
AU (1) AU606901B2 (cs)
CA (1) CA1326737C (cs)
CS (1) CS272231B2 (cs)
DE (1) DE3786250T2 (cs)
DK (1) DK641687A (cs)
ES (1) ES2056810T3 (cs)
FI (1) FI89059C (cs)
HU (1) HU203109B (cs)
IE (1) IE62334B1 (cs)
IL (1) IL84766A (cs)
MC (1) MC1881A1 (cs)
NO (1) NO171788C (cs)
NZ (1) NZ222824A (cs)
PH (1) PH25030A (cs)
PT (1) PT86366B (cs)
ZW (1) ZW23187A1 (cs)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68925240T2 (de) * 1988-06-23 1996-06-13 Banyu Pharma Co Ltd Phosphinsäure-Derivate
US5183900A (en) * 1990-11-21 1993-02-02 Galardy Richard E Matrix metalloprotease inhibitors
US5114953A (en) * 1990-11-21 1992-05-19 University Of Florida Treatment for tissue ulceration
US5189178A (en) * 1990-11-21 1993-02-23 Galardy Richard E Matrix metalloprotease inhibitors
US5239078A (en) 1990-11-21 1993-08-24 Glycomed Incorporated Matrix metalloprotease inhibitors
US5268384A (en) * 1990-11-21 1993-12-07 Galardy Richard E Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
CA2058797A1 (en) * 1991-02-01 1992-08-02 Michael John Broadhurst Amino acid derivatives
FR2676059B1 (fr) * 1991-05-02 1993-07-23 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteurs de collagenases bacteriennes.
EP0520573A1 (en) * 1991-06-27 1992-12-30 Glaxo Inc. Cyclic imide derivatives
AU3475393A (en) * 1992-01-15 1993-08-03 Merck & Co., Inc. Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
US5326760A (en) * 1992-06-29 1994-07-05 Glaxo, Inc. Aminobutanoic acid compounds having metalloprotease inhibiting properties
US6037472A (en) * 1993-11-04 2000-03-14 Syntex (U.S.A.) Inc. Matrix metalloprotease inhibitors
AU5825094A (en) * 1993-11-19 1995-06-06 Astra Aktiebolag Novel dipeptide derivatives
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
US5476847A (en) * 1994-06-29 1995-12-19 Schering Corporation Derivatives of phosphinic acid useful as endothelin converting enzyme inhibitors
US5840698A (en) * 1994-10-27 1998-11-24 Affymax Technologies N.V. Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use
US5831004A (en) * 1994-10-27 1998-11-03 Affymax Technologies N.V. Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
US6011021A (en) * 1996-06-17 2000-01-04 Guilford Pharmaceuticals Inc. Methods of cancer treatment using naaladase inhibitors
FR2730235A1 (fr) * 1995-02-06 1996-08-09 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteur de l'endopeptidase a zinc 24-15
EA003294B1 (ru) * 1995-12-08 2003-04-24 Агурон Фармасьютикалс, Инк. Ингибиторы металлопротеиназы, фармацевтические композиции, их содержащие, и их фармацевтические применения
US6500948B1 (en) 1995-12-08 2002-12-31 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
DK0780386T3 (da) * 1995-12-20 2003-02-03 Hoffmann La Roche Matrixmetalloproteaseinhibitorer
US5795877A (en) * 1996-12-31 1998-08-18 Guilford Pharmaceuticals Inc. Inhibitors of NAALADase enzyme activity
US5863536A (en) * 1996-12-31 1999-01-26 Guilford Pharmaceuticals Inc. Phosphoramidate derivatives
US5977090A (en) * 1996-09-27 1999-11-02 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating compulsive disorders using NAALADase inhibitors
US6054444A (en) * 1997-04-24 2000-04-25 Guilford Pharmaceuticals Inc. Phosphonic acid derivatives
US6071965A (en) * 1996-06-17 2000-06-06 Guilford Pharmaceuticals Inc. Phosphinic alkanoic acid derivatives
US6384022B1 (en) 1996-06-17 2002-05-07 Guilford Pharmaceuticals Inc. Prodrugs of NAALAdase inhibitors
US6046180A (en) * 1996-06-17 2000-04-04 Guilford Pharmaceuticals Inc. NAALADase inhibitors
US5672592A (en) * 1996-06-17 1997-09-30 Guilford Pharmaceuticals Inc. Certain phosphonomethyl-pentanedioic acid derivatives thereof
JP2002515040A (ja) 1996-06-17 2002-05-21 ギルフォード・ファーマシューティカルズ・インコーポレイテッド Ｎａａｌａｄアーゼ阻害剤を用いる癌治療方法
US6025345A (en) * 1996-06-17 2000-02-15 Guilford Pharmaceuticals Inc. Inhibitors of NAALADase enzyme activity
US5902817A (en) * 1997-04-09 1999-05-11 Guilford Pharmaceuticals Inc. Certain sulfoxide and sulfone derivatives
US6025344A (en) 1996-06-17 2000-02-15 Guilford Pharmaceuticals Inc. Certain dioic acid derivatives useful as NAALADase inhibitors
EP0923585B1 (en) * 1996-07-18 2002-05-08 Pfizer Inc. Phosphinate based inhibitors of matrix metalloproteases
US6953788B1 (en) 1996-09-19 2005-10-11 Aventis Pharmaceuticals Inc. 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
US5962521A (en) * 1997-04-04 1999-10-05 Guilford Pharmaceuticals Inc. Hydroxamic acid derivatives
US6174915B1 (en) 1997-03-25 2001-01-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US6008243A (en) * 1996-10-24 1999-12-28 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
US5985900A (en) * 1997-04-01 1999-11-16 Agouron Pharmaceuticals, Inc. Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
US5981209A (en) * 1997-12-04 1999-11-09 Guilford Pharmaceuticals Inc. Use of NAALADase activity to identify prostate cancer and benign prostatic hyperplasia
US6028216A (en) * 1997-12-31 2000-02-22 Guilford Pharmaceuticals Inc. Asymmetric syntheses and intermediates for preparing enantiomer-enriched hydroxyphosphinyl derivatives
US6121252A (en) * 1998-03-30 2000-09-19 Guilford Pharmaceuticals Inc. Phosphinic acid derivatives
US6329418B1 (en) 1998-04-14 2001-12-11 The Procter & Gamble Company Substituted pyrrolidine hydroxamate metalloprotease inhibitors
US6265609B1 (en) 1998-07-06 2001-07-24 Guilford Pharmaceuticals Inc. Thio-substituted pentanedioic acid derivatives
MXPA01000144A (es) 1998-07-06 2002-10-17 Guilford Pharm Inc Inhibidores de naaladasa utiles como composiciones y compuestos farmaceuticos.
US6395718B1 (en) 1998-07-06 2002-05-28 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
HRP990246A2 (en) 1998-08-07 2000-06-30 Du Pont Pharm Co Succinoylamino benzodiazepines as inhibitors of a beta protein production
NZ525513A (en) 1998-08-07 2004-09-24 Pont Pharmaceuticals Du Succinoylamino lactams as inhibitors of Abeta protein production
US6737038B1 (en) 1998-11-12 2004-05-18 Bristol-Myers Squibb Company Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging
EP1129355B1 (en) * 1998-11-12 2005-07-20 Bristol-Myers Squibb Pharma Company Use of radioligands to screen inhibitors of amyloid-beta peptide production
US6313159B1 (en) 1999-08-20 2001-11-06 Guilford Pharmaceuticals Inc. Metabotropic glutamate receptor ligand derivatives as naaladase inhibitors
GB9922577D0 (en) * 1999-09-23 1999-11-24 Center For Clinical & Basic Re Substituted phosphinate based peptide derivatives
US6696456B1 (en) * 1999-10-14 2004-02-24 The Procter & Gamble Company Beta disubstituted metalloprotease inhibitors
RU2245876C2 (ru) * 2000-03-21 2005-02-10 Дзе Проктер Энд Гэмбл Компани Производные сульфонамидов и фармацевтическая композиция на их основе
CA2401728A1 (en) * 2000-03-21 2001-09-27 The Procter & Gamble Company Difluorobutyric acid metalloprotease inhibitors
WO2001070682A2 (en) * 2000-03-21 2001-09-27 The Procter & Gamble Company Carbocyclic side chain containing metalloprotease inhibitors
IL147629A0 (en) 2000-06-01 2002-08-14 Bristol Myers Squibb Pharma Co LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
US8283135B2 (en) 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
AU2003233154A1 (en) 2002-06-10 2003-12-22 Pfizer Inc. Metabolites of prinomastat and their sythesis
JP6417421B2 (ja) 2014-02-28 2018-11-07 ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． 荷電連結体及び共役体のためのその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226610A (en) * 1978-04-15 1980-10-07 Meiji Selka Kaisha, Ltd. Herbicidal compounds, preparation thereof and herbicides containing the same
JPS60163899A (ja) * 1984-02-03 1985-08-26 Sankyo Co Ltd レニン阻害ペプチド類
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
EP0209848A3 (en) * 1985-07-24 1988-07-27 Merck & Co. Inc. Enzyme inhibitors
EP0210545A3 (en) * 1985-07-24 1988-07-20 Merck & Co. Inc. Phosphorous containing enzyme inhibitors

Also Published As

Publication number Publication date
US5006651A (en) 1991-04-09
FI89059C (fi) 1993-08-10
AU8217687A (en) 1988-06-16
AU606901B2 (en) 1991-02-21
FI875484A0 (fi) 1987-12-14
DK641687A (da) 1988-06-16
EP0276436B1 (en) 1993-06-16
NO171788B (no) 1993-01-25
CN87101164A (zh) 1988-06-29
PT86366B (pt) 1990-11-20
US4885283A (en) 1989-12-05
EP0276436A1 (en) 1988-08-03
DE3786250T2 (de) 1993-10-07
ZW23187A1 (en) 1988-06-29
NO875214D0 (no) 1987-12-14
PT86366A (en) 1988-01-01
NO875214L (no) 1988-06-16
HUT46699A (en) 1988-11-28
ES2056810T3 (es) 1994-10-16
IE873383L (en) 1988-06-15
HU203109B (en) 1991-05-28
NO171788C (no) 1993-05-05
IE62334B1 (en) 1995-01-25
CS900287A2 (en) 1990-03-14
IL84766A (en) 1994-02-27
CN1017337B (zh) 1992-07-08
FI89059B (fi) 1993-04-30
PH25030A (en) 1991-01-28
FI875484A7 (fi) 1988-06-16
IL84766A0 (en) 1988-05-31
NZ222824A (en) 1990-08-28
CA1326737C (en) 1994-02-01
DE3786250D1 (en) 1993-07-22
CS272231B2 (en) 1991-01-15
DK641687D0 (da) 1987-12-07

Similar Documents

Publication Publication Date Title
US4885283A (en) Phosphinic acid derivatives
EP0462884B1 (fr) Dérivés de TRH, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0082088B1 (fr) Nouveaux dérivés d'aminoacides, et leur application thérapeutique
EP0038758B1 (fr) Dérivés d'acides aminés et leur application thérapeutique
FR2679564A1 (fr) Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent.
FR2460291A1 (fr) Nouveaux tripeptides agissant sur le systeme nerveux central et leur procede de preparation
FR2473042A1 (fr) Nouveaux derives de piperazinone utiles notamment comme intermediaire de synthese des derives de l'enkephaline, et leur preparation
EP0406119B1 (fr) Nouveaux dérivés peptidiques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0316218B1 (fr) Nouveaux dérivés de l-proline, leur préparation et leurs applications biologiques
FR2496654A1 (fr) Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent
EP0005658A1 (fr) Nouveaux dérivés de peptides analogues des enképhalines, leur procédé de préparation et leur application thérapeutique
EP0828851B1 (fr) Inhibiteurs de tripeptidylpeptidases
EP1140981B1 (fr) Composes tripeptidiques utiles a titre d'inhibiteurs selectifs de l'aminopeptidase a et compositions pharmaceutiques correspondantes
EP0354108B1 (fr) Amino-acides et peptides présentant un résidu tyrosine modifiée, leur préparation et leur application comme médicaments
EP0284461A1 (fr) Nouveaux dérivés de l'acide glutamique, leurs sels, procédé de préparation, application à titre de médicaments et compositions les renfermant
FR2602511A1 (fr) Peptides et derives peptidiques, leur preparation et leur utilisation comme medicaments
FR2577931A1 (fr) Derives aminodiols peptidiques inhibiteurs de la renine et des proteases acides, leur procede de preparation et leur application en therapeutique
CH634291A5 (fr) Peptides.
WO1994011390A1 (fr) Nouveaux derives pseudodipeptidiques, leur preparation et leur utilisation comme antagonistes de la gastrine
FR2801591A1 (fr) Derives macrocycliques de l'acide hydroxamique, leur preparation et les compositions qui les contiennent
FR2600067A1 (fr) Pseudopeptides inhibiteurs de la secretion gastrique
BE859026A (fr) Composes analgesiques
JPS63156796A (ja) ホスフイン酸誘導体
BE832190A (fr) Derives dipeptidiques et leur production
BE827479A (fr) Nouveaux tripeptides utiles comme medicaments et leur procede de preparation

Legal Events

Date Code Title Description
YP Annual fee paid